BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

682 related articles for article (PubMed ID: 11281087)

  • 1. Early detection for lung cancer. New tools for casefinding.
    Lam S; Lam B; Petty TL
    Can Fam Physician; 2001 Mar; 47():537-44. PubMed ID: 11281087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytopathological analysis of sputum in patients with airflow obstruction and significant smoking histories.
    Kennedy TC; Proudfoot SP; Franklin WA; Merrick TA; Saccomanno G; Corkill ME; Mumma DL; Sirgi KE; Miller YE; Archer PG; Prochazka A
    Cancer Res; 1996 Oct; 56(20):4673-8. PubMed ID: 8840983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung cancer screening--are we there yet?
    Warner E; Jotkowitz A; Maimon N
    Eur J Intern Med; 2010 Feb; 21(1):6-11. PubMed ID: 20122605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for lung cancer: New horizons?
    Rossi A; Maione P; Colantuoni G; Gaizo FD; Guerriero C; Nicolella D; Ferrara C; Gridelli C
    Crit Rev Oncol Hematol; 2005 Dec; 56(3):311-20. PubMed ID: 15978829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up study of a population-based 1996-1998 mass screening programme for lung cancer using mobile low-dose spiral computed tomography.
    Sone S; Nakayama T; Honda T; Tsushima K; Li F; Haniuda M; Takahashi Y; Suzuki T; Yamanda T; Kondo R; Hanaoka T; Takayama F; Kubo K; Fushimi H
    Lung Cancer; 2007 Dec; 58(3):329-41. PubMed ID: 17675180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Protocols for lung cancer screening: Limitations, and consequences].
    Clément-Duchêne C; Guillemin F; Paris C; Régent D; Martinet Y
    Rev Mal Respir; 2010 Apr; 27(4):314-28. PubMed ID: 20403542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of occult endobronchial malignancy in high risk patients with moderate sputum atypia.
    Kennedy TC; Franklin WA; Prindiville SA; Cook R; Dempsey EC; Keith RL; Hirsch FR; Merrick TA; Shroyer KR; Petty TL; Byers T; Bunn PA; Miller YE
    Lung Cancer; 2005 Aug; 49(2):187-91. PubMed ID: 16022912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for lung cancer--a review.
    Kuzniar T; Masters GA; Ray DW
    Med Sci Monit; 2004 Feb; 10(2):RA21-30. PubMed ID: 14737058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sputum cytology examination followed by autofluorescence bronchoscopy: a practical way of identifying early stage lung cancer in central airway.
    Lam B; Lam SY; Wong MP; Ooi CG; Fong DY; Lam DC; Lai AY; Tam CM; Pang CB; Ip MS; Lam WK
    Lung Cancer; 2009 Jun; 64(3):289-94. PubMed ID: 19010567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lung cancer screening -- state of the art].
    Nowak D; Ochmann U; Huber RM; Diederich S
    Pneumologie; 2005 Mar; 59(3):178-91. PubMed ID: 15756631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for lung cancer in high-risk groups: current status of low-dose spiral CT scanning and sputum markers.
    Jett JR
    Semin Respir Crit Care Med; 2000; 21(5):385-92. PubMed ID: 16088750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung cancer screening--where we are in 2004 (take home messages).
    Deppermann KM
    Lung Cancer; 2004 Aug; 45 Suppl 2():S39-42. PubMed ID: 15552780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving early detection of COPD: the role of spirometry screening assessment.
    Holt K
    Prof Nurse; 2004 Nov; 20(3):31-3. PubMed ID: 15552437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of novel biological tools used in screening for the early detection of lung cancer.
    Ghosal R; Kloer P; Lewis KE
    Postgrad Med J; 2009 Jul; 85(1005):358-63. PubMed ID: 19581246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Early diagnosis of lung cancer: where do we stand?].
    Hammerschmidt S
    MMW Fortschr Med; 2006 Jun; 148(22):28, 30-1. PubMed ID: 16821577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung cancer. Screening, counseling, and treating long-term smokers.
    Wisnivesky JP; Szwarcberg JB; McGinn TG
    Geriatrics; 2002 Nov; 57(11):28-32. PubMed ID: 12442566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung cancer screening: a different paradigm.
    McWilliams A; Mayo J; MacDonald S; leRiche JC; Palcic B; Szabo E; Lam S
    Am J Respir Crit Care Med; 2003 Nov; 168(10):1167-73. PubMed ID: 12882756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spirometric and anthropometric determinants of forced expiratory time in a general population.
    Kainu A; Lindqvist A; Sarna S; Sovijärvi A
    Clin Physiol Funct Imaging; 2008 Jan; 28(1):38-42. PubMed ID: 18171402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Office-based spirometry for early detection of obstructive lung disease.
    Wallace LD; Troy KE
    J Am Acad Nurse Pract; 2006 Sep; 18(9):414-21. PubMed ID: 16958772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
    Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
    Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.